Clinical trial
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00178971 |
|---|---|
| Title | Serotonin 1A Agonists and Cognition in Schizophrenia |
| Official title | Serotonin 1A Agonists and Cognition in Schizophrenia |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | adjunctive treatment with buspirone, placebo |
| Enrollment | 60 |
| Start date | Jan 1, 2003 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 7, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: